Preclinical HbA1c level studies of makaradhwaja and siddha makaradhwaja after chronic administration to male Sprague-Dawley rats
Keywords:Diabetes mellitus, HbA1c, Makaradhwaja, Siddha Makaradhwaja
Background: Makaradhwaja (MD) and Siddha Makaradhwaja (SMD) are Ayurvedic preparations used as traditional medicines for different clinical indications in the rural population. Principle purpose of using MD is controlling hypotension and while SMD is useful in peripheral circulatory failure treatment. In this study we evaluate the influence of these preparations on HbA1c (%) level.
Methods: To find out the average plasma glucose concentration over prolonged period of time, MD and SMD were administered chronically to the male Sprague-Dawley rats at a dose of 40 mg/kg. After 28 days of chronic administration of MD and SMD the following changes were noted and Glycated Hemoglobin (HbA1c) level was determined.
Results: The results of the study of in vitro quantitative determination of rat HbA1c concentrations in serum studies, MD demonstrated a negligible (0.61%) decrease in the HbA1c level of the blood of the male rat (p=0.902). Whereas SMD demonstrated a negligible (1.83%) increase in the HbA1c level of the blood of the male rat (p=0.782).
Conclusions: Between these preparation MD slightly decreases HbA1c level of the blood of the male rat, whereas SMD found in increasing HbA1c level of the blood of the male rat.
Khedekar SB, Prajapati PK, Galib R, Patgiri B. A scientific review of gold containingherbo-mineral preparation: Makaradhwaja. International Journal of Green Pharmacy (IJGP). 2016;9(4).
Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. Efficacy and safety evaluation of Ayurvedic treatment (Ashwagandha powder and Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. Indian Journal of Medical Research. 2015;141(1):100.
Kapoor RC. Some observations on the metal-based preparations in Indian systems of medicine. Indian journal of Traditional Knowledge. 2010;9(3):562-75.
Saggu S, Kumar RS, Singh VK, Govil JN. Stress management and herbal adaptogens. Chem Med Value. 2009;25:253-71.
Charde R, Sharma R, Patgiri BJ, Prajapati PK. Efficacy of Makaradhwaja on Madhumeha (Type2 diabetes): A review through ayurvedic studies. AJPCT; 2014;2:1470-9.
Kamath SU, Pemiah B, Sekar RK, Krishnaswamy S, Sethuraman S, Krishnan UM. Mercury-based traditional herbo-metallic preparations: a toxicological perspective. Archives of toxicology. 2012;86(6):831-8.
Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N. Review article: diabetes, genetics and ethnicity. Alimentary pharmacology and therapeutics. 2005;22(2):16-9.
Weykamp C. HbA1c: a review of analytical and clinical aspects. Annals of laboratory medicine. 2013;33(6):393-400.
Alzahrani SH, Ajjan RA. Review article: Coagulation and fibrinolysis in diabetes. Diabetes and Vascular Disease Research. 2010;7(4):260-73.
Cavagnolli G, Comerlato J, Comerlato C, Renz P, Gross JL, Camargo JL. HbA1c measurement for the diagnosis of diabetes: is it enough? Diabetic Medicine. 2011;28(1):31-5.
Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabetic Medicine. 2007;24(4):333-43.
Procopiou M. HbA1c: review and recent developments. Revue Medicale Suisse. 2006;2(68):1473-4.
Ngiam KY, Lee WJ, Lee YC, Cheng A. Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2: a review. Obesity surgery. 2014;24(1):148-58.
Karsdal MA, Krarup H, Sand JMB, Christensen PB, Gerstoft J, Leeming DJ, et al. Review article: The efficacy of biomarkers in chronic fibroproliferative diseases–early diagnosis and prognosis, with liver fibrosis as an exemplar. Alimentary pharmacology and therapeutics. 2014;40(3):233-49.
Levitan EB, Liu S, Stampfer MJ, Cook NR, Rexrode KM, Ridker PM, et al. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2008;51(2):267-75.
Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and experimental medicine. 2007;7(1):24-9.
Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabetic medicine. 2005;22(12):1726-30.
Zander R, Lang W, Wolf HU. Alkaline haematin D-575, a new tool for the determination of haemoglobin as an alternative to the cyanhaemiglobin method, I. Description of the method. Clin Chim Acta. 1984;136(1):83-93.
Robers M, Van der Hulst FF, Fischer MA, Roos W, Salud CE, Eisenwiener HG, et al. Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. Clinical chemistry. 1998;44(7):1564-7.
Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of mercury based Ayurvedic formulation (Sidh Makardhwaj) on brain cerebrum, liver and kidney in rats. The Indian J of Med Res. 2014;139(4):610.
Vidyashankar S, Godavarthi A, Varma RS, Nandakumar KS. Water-soluble compounds in the herbal preparation Abana inhibit lipid biosynthesis and enhance cholesterol efflux in HepG2 cells. Canadian journal of physiology and pharmacology. 2010;88(4):456-64.
Rao BV, Srikumar BN, Rao BS. Herbal Remedies to Treat Anxiety Disorders. Anxiety; 2009:85.
Esposito K, Chiodini P, Bellastella G, Maiorino MI, Giugliano D. Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes, Obesity and Metabolism. 2012;14(3):228-33.
Ngiam KY, Lee WJ, Lee YC, Cheng A. Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2 -a review. Obesity surgery. 2014;24(1):148-58.
Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. The effect of correction of anaemia in diabetics and non‐diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrology Dialysis Transplantation. 2003;18(1):141-6.
Kohan DE, Fioretto P, Tang W, List JF. Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Kidney international. 2014;85(4):962-71.
Kang JG, Park CY. Anti-obesity drugs: a review about their effects and safety. Diabetes and Metabolism Journal. 2012;36(1):13-25.